EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study-论文-万方医学网

首页> > EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

导出原文传递

翻译打印收藏纠错

第一作者： Chang Q.

作者： Chang Q. ^[1] ; Xu J. ^[2] ; Qiang H. ; Teng J. ; Qian J. ; Lv M. ; Zhang Y. ; Lou Y. ; Zhao Y. ; Zhong R. ; Han B. ; Chu T.

作者单位： Pulmonary Department Shanghai Chest Hospital Shanghai Jiaotong University ^[1] Department of Immunology Key Laboratory of Medical Molecular Virology of Ministries of Education ^[2]

关键词 Chemotherapy EGFR-TKI therapy Gradual disease progression Mutation-negative EGFR-T790M NSCLC

发布时间 2022-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

相似文献

同项目论文

相关期刊

检索历史 清除

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

相似文献

同项目论文

相关期刊

检索历史清除